BIOKEY
ActiveFinancials · financial year 2026, abbreviated format
Annual accounts 2026 filed on 01-10-2026 at the NBB all 7 filings
Equity
-€220,187▼ 8.3%
2025 · -€203,275
Total assets
€2,606▲ 35.0%
2025 · €1,931
Net result
-€16,912▲ 36.7%
2025 · -€26,728
Working capital
-€143,878▼ 13.3%
2025 · -€126,967
Multi-year overview
2020 to 2026, 7 financial yearsOperating result
-€16,797
▲ 37.1%
2026
20202026
Net result
-€16,912
▲ 36.7%
2026
20202026
Equity
-€220,187
▼ 8.3%
2026
20202026
Total assets
€2,606
▲ 35.0%
2026
20202026
Debt
€222,793
▲ 8.6%
2026
20202026
Working capital
-€143,878
▼ 13.3%
2026
20202026
Solvency
no figure
2026
20202026
Current ratio
no figure
2026
20202026
Return on assets (ROA)
no figure
2026
20202026
Every figure per financial year
Every figure with its change against the financial year before
favourable
unfavourable
Line2020202120222023202420252026
Operating result-€62,372--€26,584▲ 57.4%-€4,967▲ 81.3%-€51,616▼ 939%-€48,819▲ 5.4%-€26,684▲ 45.3%-€16,797▲ 37.1%
Net result-€62,882--€27,733within the sector's middle half▲ 55.9%-€5,418within the sector's middle half▲ 80.5%-€54,899within the sector's middle half▼ 913%-€48,865within the sector's middle half▲ 11.0%-€26,728within the sector's middle half▲ 45.3%-€16,912▲ 36.7%
Equity-€39,632--€67,365below the sector's middle half▼ 70.0%-€72,783below the sector's middle half▼ 8.0%-€127,682below the sector's middle half▼ 75.4%-€176,547below the sector's middle half▼ 38.3%-€203,275below the sector's middle half▼ 15.1%-€220,187▼ 8.3%
Total assets€10,265-€10,243below the sector's middle half▼ 0.2%€6,966below the sector's middle half▼ 32.0%€20,869below the sector's middle half▲ 200%€5,582below the sector's middle half▼ 73.2%€1,931below the sector's middle half▼ 65.4%€2,606▲ 35.0%
Debt€49,897-€77,608▲ 55.5%€79,749▲ 2.8%€148,551▲ 86.3%€182,129▲ 22.6%€205,205▲ 12.7%€222,793▲ 8.6%
Working capital€4,976-€5,586below the sector's middle half▲ 12.3%€691below the sector's middle half▼ 87.6%-€51,074below the sector's middle half-€100,239below the sector's middle half▼ 96.3%-€126,967below the sector's middle half▼ 26.7%-€143,878▼ 13.3%
Solvency-386.1%--657.7%below the sector's middle half▼ 271.6pp-611.8%below the sector's middle half
Current ratio2.00-2.22within the sector's middle half▲ 0.221.11within the sector's middle half▼ 1.110.29below the sector's middle half▼ 0.820.05below the sector's middle half▼ 0.24
Return on assets (ROA)-612.6%--270.7%below the sector's middle half▲ 341.8pp-77.8%below the sector's middle half▲ 193.0pp-263.1%below the sector's middle half▼ 185.3pp-875.3%below the sector's middle half▼ 612.3pp
above
within
below
The sector band is the middle half of the companies in Scientific research and development (NACE 72). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30.
The operating result for 2026 is a loss of €16,797, smaller than the loss of €26,684 in 2025.
Turnover and EBIT margin are not published. The abbreviated or micro format does not require them.
Key figures and ratios
Debt ≤ 1 year
€146,485▲
2025 · €128,897
Debt > 1 year
€76,308=
2025 · €76,308
The ratios are withheld because a balance sheet total of €2,606 is too small for a meaningful ratio.
Green means a favourable move, even when the figure itself falls, as with debt or debt to equity.
Annual accounts
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Change |
|---|---|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €394 | €233 | €72 | €0 | - | - | - | - |
| Other operating charges640/8 | - | €464 | €225 | €806 | €531 | €698 | €718 | ▲ 2.9% |
| Gross operating margin9900 | -€56,424 | -€25,887 | -€4,669 | -€50,810 | -€48,288 | -€25,987 | -€16,079 | ▲ 38.1% |
| Operating profit (loss)9901 | -€62,372 | -€26,584 | -€4,967 | -€51,616 | -€48,819 | -€26,684 | -€16,797 | ▲ 37.1% |
| Financial income75/76B | - | €0 | - | - | €0 | €0 | - | - |
| Recurring financial income75 | €0 | €0 | - | - | €0 | €0 | - | - |
| Financial charges65/66B | - | €1,149 | €451 | €3,283 | €46 | €44 | €115 | ▲ 165% |
| Recurring financial charges65 | €510 | €1,149 | €451 | €3,283 | €46 | €44 | €115 | ▲ 165% |
| Profit (loss) for the period before taxes9903 | -€62,882 | -€27,733 | -€5,418 | -€54,899 | -€48,865 | -€26,728 | -€16,912 | ▲ 36.7% |
| Profit (loss) for the period9904 | -€62,882 | -€27,733 | -€5,418 | -€54,899 | -€48,865 | -€26,728 | -€16,912 | ▲ 36.7% |
| Profit (loss) for the period to be appropriated9905 | -€62,882 | -€27,733 | -€5,418 | -€54,899 | -€48,865 | -€26,728 | -€16,912 | ▲ 36.7% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Change |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total assets20/58 | €10,265 | €10,243 | €6,966 | €20,869 | €5,582 | €1,931 | €2,606 | ▲ 35.0% |
| Fixed assets21/28 | €305 | €72 | €0 | - | - | - | - | - |
| Tangible fixed assets22/27 | €305 | €72 | €0 | - | - | - | - | - |
| Furniture and vehicles24 | - | €72 | €0 | - | - | - | - | - |
| Current assets29/58 | €9,960 | €10,171 | €6,966 | €20,869 | €5,582 | €1,931 | €2,606 | ▲ 35.0% |
| Amounts receivable within one year40/41 | €1,018 | €7,547 | €6,857 | €3,247 | €5,001 | €1,315 | €369 | ▼ 71.9% |
| Trade receivables40 | - | €1,815 | €0 | - | - | - | - | - |
| Other amounts receivable41 | - | €5,732 | €6,857 | €3,247 | €5,001 | €1,315 | €369 | ▼ 71.9% |
| Cash at bank and in hand54/58 | €8,942 | €2,489 | €109 | €17,622 | €581 | €616 | €2,036 | ▲ 231% |
| Deferred charges and accrued income490/1 | - | €135 | €0 | - | - | - | €201 | - |
| Equity and liabilities | ||||||||
| Total equity and liabilities10/49 | €10,265 | €10,243 | €6,966 | €20,869 | €5,582 | €1,931 | €2,606 | ▲ 35.0% |
| Equity10/15 | -€39,632 | -€67,365 | -€72,783 | -€127,682 | -€176,547 | -€203,275 | -€220,187 | ▼ 8.3% |
| Contributions10/11 | - | €23,250 | €23,250 | €23,250 | €23,250 | €23,250 | €23,250 | = |
| Profit (loss) carried forward14 | -€62,882 | -€90,615 | -€96,033 | -€150,932 | -€199,797 | -€226,525 | -€243,437 | ▼ 7.5% |
| Amounts payable17/49 | €49,897 | €77,608 | €79,749 | €148,551 | €182,129 | €205,205 | €222,793 | ▲ 8.6% |
| Amounts payable after more than one year17 | €44,469 | €71,913 | €73,023 | €73,474 | €76,308 | €76,308 | €76,308 | = |
| Other amounts payable178/9 | - | €71,913 | €73,023 | €73,474 | €76,308 | €76,308 | €76,308 | = |
| Amounts payable within one year42/48 | €4,984 | €4,585 | €6,275 | €71,943 | €105,821 | €128,897 | €146,485 | ▲ 13.6% |
| Trade debts44 | €4,984 | €4,585 | €6,130 | €15,472 | €9,497 | €0 | - | - |
| Suppliers440/4 | - | €4,585 | €6,130 | €15,472 | €9,497 | €0 | - | - |
| Other amounts payable47/48 | - | - | €145 | €56,470 | €96,324 | €128,897 | €146,485 | ▲ 13.6% |
| Accrued charges and deferred income492/3 | - | €1,110 | €451 | €3,134 | €0 | - | - | - |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Change |
|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€62,882 | -€27,733 | -€5,418 | -€54,899 | -€48,865 | -€26,728 | -€16,912 | ▲ 36.7% |
| + Depreciation and write-downs630 | €394 | €233 | €72 | €0 | - | - | - | - |
| Operating cash flow (approximation) | -€62,488 | -€27,500 | -€5,346 | -€54,899 | -€48,865 | -€26,728 | -€16,912 | ▲ 36.7% |
| Investment in fixed assets (approximation) | - | €0 | €0 | - | - | - | - | - |
| Change in cash | - | -€6,453 | -€2,380 | €17,513 | -€17,041 | €34 | €1,420 | ▲ 41× |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Historical observation
In July 2024, 6,008 companies had the same profile as BIOKEY has now. Two years later, 83.0% were still going and 7.9% had gone bankrupt.
- Micro
- 5 to 10 years old
- negative equity
- a loss of 10% of the balance sheet or more
83.0%
was still going
8.4%
stopped otherwise
7.9%
went bankrupt
Another 0.8% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of BIOKEY itself is lower: 0.5% within 12 months. It rests on far more data about BIOKEY than the profile alone.
Test of the method
The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 6,008 companies, not a prediction for BIOKEY. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Filings with the National Bank (7)
| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 30-04-2026 | abbreviated format | 01-10-2026 | 2026-00542843 | |
| 30-04-2025 | abbreviated format | 17-09-2025 | 2025-00495725 | |
| 30-04-2024 | abbreviated format | 29-11-2024 | 2024-00609461 | |
| 30-04-2023 | abbreviated format | 20-12-2023 | 2023-00532383 | |
| 30-04-2022 | abbreviated format | 29-12-2022 | 2023-20550720 | |
| 31-12-2021 | abbreviated format | 31-07-2022 | 2022-20276101 | |
| 31-12-2020 | micro format | 30-06-2021 | 2021-27800181 |